Safety, Immunogenicity and Consistency of Three Manufacturing Lots of GSK Biologicals' dTpa Candidate Vaccine as Compared to a U.S.-Licensed Td Vaccine (m PHBL) When Given a a Booster Dose to Healthy Adolescents (10-18 yrs)